Results 261 to 270 of about 2,389,723 (301)
Some of the next articles are maybe not open access.
Acta Ophthalmologica, 2012
AbstractPurpose To assess safety and efficacy of intraocular injections of anti‐VEGF in patients with diabetic macular edema (DME)Methods The gold standard for treatment has been laser coagulation. Limitations of this therapy are refractive DME, ischemic diabetic maculopathy and complications after laser application.
openaire +1 more source
AbstractPurpose To assess safety and efficacy of intraocular injections of anti‐VEGF in patients with diabetic macular edema (DME)Methods The gold standard for treatment has been laser coagulation. Limitations of this therapy are refractive DME, ischemic diabetic maculopathy and complications after laser application.
openaire +1 more source
Acta Ophthalmologica, 2014
AbstractVascular endothelial growth factor A (VEGF‐A) was initially discovered as an endothelial cell‐specific growth factor, and current evidence suggests that it also plays numerous roles outside the vasculature, perhaps most significantly in the nervous system.
openaire +1 more source
AbstractVascular endothelial growth factor A (VEGF‐A) was initially discovered as an endothelial cell‐specific growth factor, and current evidence suggests that it also plays numerous roles outside the vasculature, perhaps most significantly in the nervous system.
openaire +1 more source
Anti-VEGF-Resistant Retinal Diseases: A Review of the Latest Treatment Options
Cells, 2021Ron P Gallemore
exaly